.png){kind=icon}
返回
D
David R. Pearson
university of minnesota
27H指数
148论文数
2.6K被引数
收录论文 31
发表时间
.png){kind=icon}
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial恩帕托兰，一种Toll样受体7/8抑制剂，在中重度系统性红斑狼疮中的应用：一项多中心、国际性、双盲、安慰剂对照剂量探索II期试验Cohort B的研究结果.png)
The Lancet.png)
OAAI
The LancetIF88.5
OAAI.png){kind=icon}
分享.png){kind=icon}
收藏Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial恩帕托兰（一种Toll样受体7/8抑制剂）在具有皮肤表现的皮肤狼疮或系统性红斑狼疮患者中的疗效与安全性：一项多中心、国际性、双盲、安慰剂对照、剂量探索性2期试验中Cohort A的结果
PREAI
分享收藏